brimonidine tartrate has been researched along with Ptosis, Eyelid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sloan, B | 1 |
Mehta, I; Rehmani, A; Smith, E | 1 |
Bocaccio, FJ; Lummertz, AP; Mendonça, TB; Procianoy, F | 1 |
deSousa, JL; Malhotra, R | 1 |
4 other study(ies) available for brimonidine tartrate and Ptosis, Eyelid
Article | Year |
---|---|
This month in JAAD Case Reports: July 2022: Eyelid ptosis treated with brimonidine gel.
Topics: Blepharoplasty; Blepharoptosis; Brimonidine Tartrate; Eyelids; Humans | 2022 |
Treatment of Ptosis Using Brimonidine Tartrate for Anterior Laminectomy-Induced Horner Syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Blepharoptosis; Brimonidine Tartrate; Diskectomy; Female; Horner Syndrome; Humans; Middle Aged; Postoperative Complications; Spinal Fusion; Treatment Outcome | 2020 |
Effect of Low-Concentration, Nonmydriatic Selective Alpha-Adrenergic Agonist Eyedrops on Upper Eyelid Position.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Blepharoptosis; Botulinum Toxins; Brimonidine Tartrate; Eyelids; Humans; Middle Aged; Naphazoline; Ophthalmic Solutions; Phenylephrine; Young Adult | 2017 |
Brimonidine for anisocoria.
Topics: Adrenergic alpha-Agonists; Adult; Anisocoria; Blepharoptosis; Brimonidine Tartrate; Female; Horner Syndrome; Humans; Quinoxalines; Treatment Outcome | 2007 |